NCT07389928

Brief Summary

To systematically evaluate multiple biomarkers in patients ventricular tachycardia (VT), premature ventricular contractions (PVC), atrioventricular nodal reentrant tachycardia (AVNRT) undergoing catheter ablation to elucidate their mechanistic relevance and predictive value.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
54mo left

Started Apr 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Apr 2026Oct 2030

First Submitted

Initial submission to the registry

January 28, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2030

Last Updated

February 5, 2026

Status Verified

January 1, 2026

Enrollment Period

4.5 years

First QC Date

January 28, 2026

Last Update Submit

January 28, 2026

Conditions

Arrhythmia

Outcome Measures

Primary Outcomes (1)

  • Association between baseline biomarker profiles and arrhythmia subtype (VT, PVC, AVNRT).

    24 months

Study Arms (1)

General cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ventricular tachycardia (VT), premature ventricular contractions (PVC), atrioventricular nodal reentrant tachycardia (AVNRT) undergoing catheter ablation.

You may qualify if:

  • Age ≥ 18 years
  • Catheter ablation due to VT, PVC, or AVNRT
  • Written informed consent

You may not qualify if:

  • Infection or inflammatory disease at time of sampling
  • Pregnancy
  • Inability to comply with study procedures
  • Life expectancy \< 1 year not due to arrhythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Department of Rhythmology

Study Record Dates

First Submitted

January 28, 2026

First Posted

February 5, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2030

Last Updated

February 5, 2026

Record last verified: 2026-01